The Ceramide Glucosyltransferase pipeline drugs market research report outlays comprehensive information on the Ceramide Glucosyltransferase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the Ceramide Glucosyltransferase pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Metabolic Disorders, Genetic Disorders, Toxicology, and Genito Urinary System which include the indications Fabry Disease, Sandhoff Disease (Jatzkewitz-Pilz Syndrome), Tay-Sachs Disease, Gastrointestinal Radiation Toxicity, Mustard Gas (Sulfur Mustard) Poisoning, Acute Renal Failure (ARF) (Acute Kidney Injury), and Kidney Fibrosis. It also reviews key players involved in Ceramide Glucosyltransferase targeted therapeutics development with respective active and dormant or discontinued products.
The Ceramide Glucosyltransferase pipeline targets constitutes close to 12 molecules. Out of which, approximately 11 molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Phase III, Phase II, Phase I, and Preclinical stages are 4, 2, 2, and 3 respectively. Similarly, the universities portfolio in Discovery comprises 1 molecule.
Ceramide Glucosyltransferase overview
Ceramide glucosyltransferase (UGCG) is a glucosyltransferase enzyme involved in the production of glucocerebroside. It catalyzes the first glycosylation step in the biosynthesis of glycosphingolipids, which are membrane components containing lipid and sugar moieties. The product of this reaction is glucosylceramide, which is the core structure of many glycosphingolipids.
For a complete picture of Ceramide Glucosyltransferase’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.